International Society on Thrombosis and Haemostasis, Inc.
 
2015 Symposia and Technical Sessions Schedule
Sunday, June 21
Special Industry Symposia
Monday, June 22
Lunch Symposia
Monday, June 22
Technical Sessions
Tuesday, June 23
Lunch Symposia
Wednesday, June 24
Lunch Symposia

Special Industry Symposia
Sunday, June 21, 2015
15:30-17:30

click symposium title for full program

Room Special Symposium
701

The Next Evolution in Personalized Hemophilia Care

Baxalta

Room Special Symposium
714

Advancing with purpose – Bayer’s commitment to hemophilia A

Bayer HealthCare

Room Special Symposium
801

New oral anticoagulants for long-term indications: Practical implications of the clinical trial data

This medical activity is supported by independent funding from Daiichi Sankyo

Room Special Symposium
718

Broadening horizons in the treatment of haemophilia and rare bleeding disorders:
rFVIII (turoctocog alfa), rFXIII (Catridecacog) and N9-GP


Novo Nordisk

 

Lunch Symposia
Monday, June 22, 2015
12:15-13:45

click symposium title for full program

Room Symposium
701

Changing the Treatment Paradigm for von Willebrand Disease and TTP

Baxalta

Room Symposium
801

Real-world experiences with prolonged half-life rFVIIIFc in hemophilia A: New data and future prospects

Biogen and Sobi

Room Symposium
717

New Frontiers in Managing Thrombotic Disease- Boldly Going Where No NOAC Has Gone Before

BMS-Pfizer

Room Symposium
715

Changing the face of anticoagulation: are YOU in?

Boehringer Ingelheim

Room Symposium
714

Pioneering therapeutic proteins in hemophilia care through innovative technologies

CSL Behring

Room Symposium
718

30 years of research with rFVIIa (eptacog alfa activated): modern patient care with an established treatment option

Novo Nordisk

Room Symposium
716

Optimizing responses to therapy in hemophilia B: treatment individualization in an era of expanding options

Pfizer

 

Technical Sessions
Monday, June 22, 2015
18:30-20:00

click symposium title for full program

Room Technical Session
716

The importance of rebalancing the coagulation system: A Potential New Approach in the Management of Hemophilia

Alnylam

Room Technical Session
717

Sharing real-world experience with Fc Fusion Factors in hemophilia B: New data for rFIXFc

Biogen and Sobi

Room Technical Session
715

Technical Innovations in Hemostasis

Hyphen BioMed

Room Technical Session
713

Where do we stand in 2015 with the data at hand to treat cancer associated thrombosis?

Pfizer

Room Technical Session
714

Take your hemostasis lab to the next level

Siemens Healthcare / Sysmex Corporation

 

Lunch Symposia
Tuesday, June 23, 2015
12:15-13:45

click symposium title for full program

Room Symposium
718

How Do You Treat? An Interactive Panel on the Management of Congenital and Acquired Inhibitors

Baxalta

Room Symposium
701

Confidence in Practice...Real Life Experience in PE/DVT

Bayer HeathCare

Room Symposium
715

Test your knowledge: using NOACs in the clinic

Boehringer Ingelheim

Room Symposium
714

Reversal of old and newer anticoagulants: evolving evidence from trials

CSL Behring

Room Symposium
717

Management of Non-Vitamin K Antagonist Oral Anticoagulants: Practical Challenges and Future Perspectives

This medical activity is supported by independent funding from Daiichi Sankyo

Room Symposium
801

Haemophilia A: Individualized solutions to global challenges

Octapharma

Room Symposium
716

The role of ultrasound in hemophilia joint health: progress and perspectives from clinical practice

Pfizer

 

Lunch Symposia
Wednesday, June 24, 2015
12:15-13:45

click symposium title for full program

Room Symposium
713

Complement Dysregulation in Atypical Hemolytic Uremic Syndrome (aHUS): Approaches to Diagnosis and Management

Alexion

Room Symposium
701

Update in the Reversal of Oral Anticoagulants: New Developments and Clinical Strategies

This activity is supported by an educational grant from Baxalta US Inc.

This activity is jointly provided by Postgraduate Institute for Medicine and CMEology

Room Symposium
717

Emerging Trends and Strategies in Thrombosis Medicine: Practical Dimensions of NOAC Based Management of Acute and Extended Treatment of Venous Thromboembolism (VTE)

Funded by an independent educational grant by Bayer HealthCare

Jointly sponsored by the University of Massachusetts Medical School, Office of CME and CMEducation Resources, LLC.

Room Symposium
715

Characterization of FVIII Concentrates: Are There Differences?

Kedrion

Room Symposium
716

Elevate Patient Care - Take Management and Care of Cancer Associated Thrombosis (CAT) Patients to the Next Level

LEO Pharma

Room Symposium
801

Addressing complex issues in VWD & Haemophilia care

Octapharma

Room Symposium
714

Clinical Controversies in Bleeding Management

This activity is jointly provided by Postgraduate Institute for Medicine and Total CME

This activity is supported by an independent educational grant from Portola Pharmaceuticals

All Corporate Symposia ISTH 2015 Daily Schedule
 Key Dates

March 11, 2015
Early Registration Deadline

June 15, 2015
Online Registration Deadline

June 20-25, 2015
ISTH 2015